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Abstract: The characteristic features of nanomaterials provide rich opportunities for a broad range of
applications due to their different physicochemical properties. Nanocolloidal silver and graphenic
carbon materials differ in most physicochemical characteristics, except for their nanodimensions.
Since there is a growing demand for stem cell therapies for coronary disorders, examining cardiac
progenitor cells (CPC) in terms of their response to nanostructure treatment seems to be a reasonable
approach. Morphological studies and viability assessments were performed with CPC in vitro,
treated with small concentrations of silver nanoparticles (AgNP), hierarchical nanoporous graphenic
carbon (HNC) and their mixtures. A viability test confirmed the morphological assessment of CPC
treated with AgNP and HNC; moreover, the action of both nanomaterials was time-dependent and
dose-dependent. For AgNP, between the two of the applied concentrations lies a border between their
potential beneficial effect and toxicity. For HNC, at a lower concentration, strong stimulation of cell
viability was noted, whereas a higher dosage activated their differentiation. It is necessary to perform
further research examining the mechanisms of the action of AgNP and especially of unexplored HNC,
and their mixtures, on CPC and other cells.
Keywords: cardiac progenitor cells; hierarchical nanoporous graphenic carbon; silver nanoparticles;
chicken; nanobiotechnology
1. Introduction
The characteristic features of nanomaterials, namely small size and high specific surface area per
mass unit, provide abundant opportunities for their use in biomedical applications [1]. Nanoparticles are
used as therapeutic agents, antimicrobials, transfection vectors and fluorescent labels [2]; the broad
range of applications is due to the extremely different physicochemical properties they can possess.
As an excellent example, nanocolloidal silver nanoparticles (AgNP) and graphenic carbon materials
differ in most of their physicochemical characteristics, except for their nanodimensions. Both have
been extensively researched for possible therapeutic activity [3–5].
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AgNP belongs to the longest studied and best-characterised nanoparticles. The first experiments
concerned the antimicrobial properties of AgNP, and proved their antibacterial [6,7], antifungal [7,8]
and antiviral [9,10] properties. The next showed their lower toxicity to eukaryotic cells in vitro [11–13]
and to higher model organisms, namely nematodes and rats in vivo [14,15] compared to silver ions.
For mouse [12] and human cell lines, silver nanoparticles at high concentrations (above 5 µg/mL) are
shown to exert a cytotoxic effect. Interestingly, a low, nontoxic AgNP concentration (2.5 µg/mL and
lower) for a short period (24 h) in the same experiments induced cell activation [11–13]. For silver
nanoparticles obtained during “green synthesis” for pharmaceutical applications, antimicrobial activity
and biocompatibility, or even in some cases protective action against oxidative stress, were noted for
eukaryotic cell lines such as keratinocytes and fibroblasts, among others [3]. Surprisingly, there is a lack
of data showing how these nanoparticles in low concentrations act on cells during a long-time culture.
The influence of a range of concentrations below the toxic dosage, which may cause unexpected
metabolic or physiological changes, are very interesting because they could bring a solution for existing
health disorders. In the case of medicines, the toxicity can be determined to find the dosage which
is safe and effective at the same time, and which may have the required effect on a living organism.
Regarding AgNP, its toxicity and mechanisms have been extensively studied [16], in contrast to their
potential beneficial influence at low concentrations. Our earlier studies on chicken model revealed that
AgNP, after four weeks of oral administration, upregulates the expression of proangiogenic factors
FGF2 and VEGFA in the heart [17]. Angiogenic properties of AgNP are also confirmed in mice and in
endothelial cell line SVEC4-10 in vitro model [18]. However, it is still not clear whether this influence
on the level of the whole organism is direct, or if it is caused by stimuli sent from the other organs.
Graphene is one of the carbon allotropes. The unique property of graphene flakes is the ratio of
thickness to surface size that distinguishes this material from all the others. Graphene has unique
physicochemical properties; its key feature is the high speed of electrons, which has a broad biological
effect on different types of cells and tissues [19]. Through adhesion and binding to cell receptors,
the charge of graphene can interfere with cell membranes, thereby blocking the access to nutrients,
and leading to the activation of apoptotic mechanisms in cancer cells [20]. It has been shown that
both surface chemistry and size play key roles in controlling biodistribution, toxicity and excretion
of graphene, and, therefore, different graphene materials exert different effects on organisms [21].
The impact of functionalised graphene nanomaterials on living organisms was, therefore, investigated.
There are studies on the effect of graphene in oxidised form combined with silver nanoparticles.
These nanocomposites are a promising agent with a broad spectrum of activity against methicillin-resistant
Staphylococcus aureus strains. They can be used as platforms for the development of new materials capable of
limiting the spread of microorganisms on biomedical devices and hospital facilities. These nanocomposites
show improved antibacterial activity compared to silver nanoparticles alone [22,23]. Hierarchical
nanoporous graphenic carbon (HNC) is a special type of graphenic materials provided so far only for
heterogeneous catalysis, chromatography and energy storage applications. A simple nonchemical method
of production allows one to obtain a highly porous material with a vesicular spatial structure, highly
porous and free of harmful chemicals [24]. This nanostructure, with its properties of graphenic materials,
seems to be a promising candidate for a carrier of active compounds, with AgNP among others.
Since there is a growing demand for stem cell therapies for coronary disorders, the examination
of cardiac progenitor cells (CPC) in terms of their response for nanomaterial treatment is desirable
even in respect to simple cell morphology, as an indicator for the first visible signs of cellular response.
Morphological stem cell colony analysis is proven to contribute in the screening of quality maintenance
of regenerative medicine products [25–27]; hence, even weak microscopic magnifications would be
sufficient to register morphological changes on a cellular or colony level.
The present experiment was performed to clarify the effect of colloidal AgNP, HNC and their
mixture on CPC originating from an eight-day-old chicken embryo. The study will assess how low
concentrations of these nanomaterials affect CPC morphology and viability in the long-term culture,
to verify the possibility of their potential regenerative applications.
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2. Materials and Methods
2.1. Materials
2.1.1. The Culture of Cardiac Progenitor Cells (CPC) from Embryonic Chicken Heart
Chicken Embryos
The fertilised eggs (Gallus gallus) of Hubbard strain chickens were supplied by a commercial, local
hatchery (Marylka, Poland). The eggs were kept for 4 d at 12 ◦C. Prior to incubation, the eggs were
sterilised by UV radiation for 30 s (UVKOR). The eggs were placed in an incubator with a controlled
temperature and humidity, and automatic changing of the slope of the shelves (ALMD1 N5, FEST,
Gostyn, Poland). The eggs were incubated for 8 days under standard conditions (37 ◦C, 60% Rh).
The day when the eggs were placed into the incubator was designated as embryonic Day 0 (E0).
From Day 8, the chicken embryo (E8) cardiac progenitor cells, giving rise to heart muscle tissue,
were isolated as follows.
Isolation of Heart
At Day 8 of embryonic development, the eggshell was cut open with surgical scissors sterilised in
70% ethanol. The content of the egg was poured onto a sterile Petri dish. The embryo deprived of
foetal membranes was transferred to another Petri dish containing sterile, buffered with phosphate
physiological saline (PBS, Gibco, Plisley, UK) and decapitated. The chest and abdomen were cut open,
and the heart was isolated.
Isolation of Cells from Embryonic Heart
Dissected tissues were transferred to previously prepared sterile 2 mL Eppendorf tubes, containing
0.5 mL heated sterile trypsin (37 ◦C) (Trypsin-EDTA, Gibco) and left for 5 min to facilitate the
disintegration of the tissue into single cells. Then, mechanical homogenisation was carried out by
squeezing the tissue through sterile needles of smaller and smaller sizes (the last one of 0.45 mm× 12 mm)
using a sterile 2 mL syringe. After obtaining a homogeneous suspension of cells, 1.5 mL of fresh culture
medium heated to 37 ◦C—containing DMEM, high glucose, GlutaMAXTM (Gibco), supplemented
with 10% heat-inactivated foetal bovine serum FBS (Gibco) and 1% antibiotics-antimycotics (Gibco),
consisting of penicillin, streptomycin and amphotericin B—was added to tubes with 0.5 mL of cell
suspension to neutralise trypsin. The cell suspension was distributed to two wells of a 6-well plate,
1 mL into each of the wells. Then, 1 mL of fresh medium was added to each well. The plate was
placed in a cell culture incubator (INC 108, Memmert, Schwabach, Germany) at standard conditions
(temperature 37 ◦C, CO2 concentration 5%) and incubated until about 80% of confluence.
Cultures and Their Stabilisation in Culture Flasks Prior to the Experiment
When the confluence of primary cultures reached 80%, the cells were transferred under the
laminar chamber, safety class II (Airstream, ESCO, Hatboro, PA, USA) from 6-well plates to 25 mL
flasks. After 4 passages, flasks of cardiac progenitor cell culture confluent as close as possible to 80%,
were selected for the experiment with several concentrations of nanomaterials in a culture medium.
2.1.2. Nanomaterials
Hydrocolloidal Ag Nanoparticles
Hydrocolloidal silver nanoparticles (Nanokoloid, Warszawa, Poland) were produced with a
proprietary (Patent 3883399), nonexplosive, high voltage method, using a high purity metal (99.9999%)
and demineralised water. Colloid contained silver nanoparticles at a concentration of 50 µg/mL.
The size of the silver nanoparticles ranged from 2 nm to 35 nm.
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Hierarchical Nanoporous Graphenic Carbon Nanostructures
HNC nanostructures were provided by the Institute of Chemistry of the Military University of
Technology (Warsaw, Poland). They are formed of very thin layers of mononuclear carbon and consist
of shells (hollow carbon nanocubes) that are uniform in size, graphenic in nature, with hierarchical
nanoporosity and a specific surface area of up to 1000 m2/g. HNC nanostructures are a new material
obtained through simple physicochemical synthesis. The technology of production and physicochemical
features of HNC have been described in detail by Dyjak et al. [24].
Suspensions of Nanomaterials in the Culture Media
Suspensions of carbon nanostructures HNC at a concentration of 1000 mg/mL were prepared in
(i) deionised water and (ii) aqueous colloid of AgNP at a concentration of 50 µg/mL. The resulting
suspensions were sequentially diluted in appropriate liquid to working concentrations of 10 µg/mL for
HNC and 10 + 50 µg/mL for the combined HNC + AgNP. Furthermore, the third working suspension
was AgNP at a concentration of 50 µg/mL. Before each application, suspensions were subjected to
30 min of sonication (ULTRON, model 908). Media with nanomaterials were prepared on an ongoing
basis, just before replacing the media in the tested cultures. Working suspensions were added to the
culture media at 20% of the final volume (1:5 dilution). For lower concentrations of nanomaterials,
the medium was further diluted five times with pure medium.
2.2. Methods
2.2.1. Zeta Potential Measurement
Zeta potential is a measure of the effective electrical charge on the surface of the nanoparticle.
When a nanoparticle has a surface charge, it is determined by the concentration of ions with opposite
charge near to the surface of the nanoparticle. This layer of oppositely charged ions moves with the
nanoparticle. The zeta potential is a measure of the difference in potential between the fluid in which
the particle is dispersed and the fluid layer containing oppositely charged ions that are bound to the
surface of the nanoparticles. Particles with negative zeta potential bind to a positively charged surface
and vice versa [28].
Aqueous suspensions of applied nanomaterials and their suspensions in the culture medium at
concentrations of the content in the culture media, were prepared by diluting the working solution
in deionised water, and then sonication (ULTRON, model 908, Olsztyn, Poland) for 30 min at room
temperature. Analysis of the preparations was performed using the device ZetaSizer (Nano ZS 90,
Malvern Instruments, Malvern, UK) with Software 7.11. Each sample of aqueous suspension was
stabilised by 120 s at 25 ◦C. Then, three 20-fold measurements were made for each sample.
2.2.2. pH Measurement
pH measurement can be used to determine the acidity or alkalinity of water solution, which is
also a culture medium. Measurements were performed by electrochemical method on Orion Star A111
benchtop pH metre standard kit with a general-purpose pH/ATC electrode in triplicate after calibration
on three standards: pH 1.0; pH 7.01; pH 10.00. After each measurement, the electrode was rinsed with
deionised water and dried with a paper towel.
2.2.3. Viability Test
To examine cell viability after incubation with nanostructures, PrestoBlue test (Life Technologies,
Carlsbad, CA, USA) was applied. PrestoBlue is a reagent that is reduced by living cells, giving a
colourful reaction that makes spectrophotometric reading possible. The test outcome does not reflect
directly the rate of cell proliferation or their number because the reduction of the reagent is possible
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also for not dividing cells, being the reason why the measurement of the viability of all living cells is
possible no matter whether their vital processes are rapid or very slow and the phase of the cell cycle.
CPCs of the fourth passage were inoculated into a 96-well plate and incubated overnight at
37 ◦C. The next day, the control medium was removed from the wells and replaced by media with
nanomaterials that were applied in the experiment, adding 90 µL of the medium and then 10 µL of the
PrestoBlue reagent (Invitrogen, United States) to the wells in 6 repetitions for each treatment. The same
media were poured into empty wells to obtain the readings of blank samples. The plate was incubated
for 30 min in a cell culture incubator, under standard conditions, then the fluorescence was measured
in individual wells on a microplate reader (Infinite M200 TECAN, Tecan i-Control 1.4 software, Zurich,
Switzerland). As the nanostructures had their own fluorescence, the results for blank samples (media +
nanostructures) were subtracted from the results of real samples (medium + nanostructures + cells).
The results developed in this way were subjected to statistical analysis. Fluorescence reading took
place at a wavelength of 590 nm. The excitation wavelength was 560 nm. Fluorescence was read again
after 2, 24 and 48 h of incubation.
2.2.4. Giemsa and May-Grünwald Staining
From the flasks with cell culture, the medium was removed. Flasks were washed twice with
non-sterile PBS. Approximately 1.5 mL of 4% paraformaldehyde (PFA, Sigma-Aldrich, Poznan, Poland)
cooled to 4 ◦C, was poured into flasks which were allowed to stand in the refrigerator (4 ◦C) for 10 min.
After this time, the flasks were again washed twice with non-sterile PBS. On the fixed cells, 1.5 mL of
May-Grünwald dye was applied (Sigma-Aldrich). After 3 min, 1.5 mL of non-sterile PBS, was poured
into flasks, mixed and left for an additional 5 min. Reagents were then removed, and the cells were
rinsed with non-sterile PBS again. Then 1.5 mL of Giemsa dye was added (Sigma-Aldrich), diluted
in phosphate buffer at a ratio of 1:9 and filtered. After 15 min, the dye was removed, and cells were
washed three times with distilled water. Flasks were allowed to dry.
2.2.5. Optical Microscopy
Pictures showing the morphology of cells in culture were taken using an inverted optical
microscope (Olympus CKX41, Shinjuku, Tokyo, Japan) with the installed camera (ProgRes C12 plus,
ProgRes Capture v. 2.8.0 software, Jenoptic, Jena, Germany).
2.2.6. Transmission Electron Microscopy
Pictures showing the morphology and structure of nanomaterials were taken with a transmission
electron microscope (TEM). Solutions of each kind of nanomaterial and the mixture of them were
sonicated for 15 min at room temperature, and then droplets of samples were put on Formvar-coated
300 mesh Cu grids (Agar Scientific Ltd., Stansted, Essex, UK). The samples were dried at room
temperature and observed using a JEM-2000EX TEM (JEOL, Akishima, Tokyo, Japan).
2.2.7. Statistical Analysis
The data obtained from fluorescence measurements were analysed using one way and multi-way
analysis of variance ANOVA, using Statgraphics Plus 4.1 (StatPoint Technologies, Warrenton, VA,
USA). One-way ANOVA was applied to determine the influence of nanostructures on cell viability.
Multivariate ANOVA served to additionally evaluate the influence of these materials during the
time. To determine whether the differences were statistically significant, Fisher’s exact test was
used. The results were presented as mean values. Differences between groups at p ≤ 0.05 were
considered significant.
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3. Results
3.1. Morphology and Structure of Nanomaterials
The TEM images of applied nanostructures and their mixtures are presented in Figure 1. It was
seen that both nanomaterials substantially differed in shape and structure (Figure 1A,B). Moreover,
these materials mutually influenced the morphology and agglomeration of each other (Figure 1C,D).
Individual HNC shells were less compacted and seemed to be thinner and less porous.
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In general, HNC seemed to be less spongy when mixed with AgNP colloid (Figure 1C). AgNP,
in turn, agglomerated on the surface of HNC creating aggregates of smaller nanoparticles around the
bigger ones (Figure 1C,D). As shown in Figure 1D, none of AgNP agglomerates existed separately
from HNC.
3.2. Zeta Potential
The results of the measurements of nanostructures zeta potential in water solutions are presented
in Table 1.
Table 1. The results of measuring the zeta potential of suspensions: of silver nanoparticles (AgNP),
carbon nanostructures (HNC) and the mixture of silver nanoparticles and carbon nanostructure
(AgNP + HNC).
Nanostructures Concentration (µg/mL) Zeta Potential (mV)
AgNP 2 −14.3
AgNP 10 −20.0
HNC 0.4 −11.2
HNC 2 −12.2
AgNP + HNC 2 + 0.4 −15.4
AgNP + HNC 10 + 2 −13.3
Measured values of the zeta potential of the nanomaterials’ suspensions ranged from −11.2 to
−20.0 mV. The results of the measurements of nanostructures zeta potential in culture media are
presented in Figure 2.
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Figure 2. (a) Zeta potential of individual media with nanostructures. (b) pH values of individual media
with nanostructures. (A) control medium; (B) medium with 2 µg/mL AgNP; (C) medium with 10 µg/mL
AgNP; (D) medium with 0.4 µg/mL HNC; (E) medium with 2 µg/mL HNC; (F) medium with 2 µg/mL
AgNP and 0.4 µg/mL HNC; (G) medium with 10 µg/mL AgNP and 2 µg/mL HNC. a–c Statistically
significant differences (p < 0.0001).
3.3. pH of Culture Media
The res lts of pH measurements in individual culture media are presented in Figure 2b.
They showed no significant differences.
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3.4. Viability Test and Cells’ Morphology
The results of multifactor ANOVA showed that the time of nanostructure action on CPC is
the main factor influencing their viability (Table 2). Regardless of the applied treatment, the most
pronounced effects were observed between particular time points of CPC culture. The influence of time
was so strong that in this type of statistical analysis, the effects of nanotreatment were not significant.
Table 2. The mean viability level of cardiac progenitor cells (CPC) culture in timepoints. (A) control
culture; (B) culture with 2 µg/mL AgNP; (C) culture with 10 µg/mL AgNP; (D) culture with 0.4 µg/mL
HNC; (E) culture with 2 µg/mL HNC; (F) culture with 2 µg/mL AgNP and 0.4 µg/mL HNC; (G) culture
with 10 µg/mL AgNP and 2 µg/mL HNC. a–c Statistically significant differences (p < 0.0001). All the
data presented as mean fluorescence intensity (MFI).
Time
Treatment Mean Value in
Time Point
Standard
ErrorA B C D E F G
2 h 538 766 783 798 524 693 956 723 a 139
24 h 9680 11,381 745 13,749 11,866 9880 1019 8251 b 139
48 h 17,815 21,449 464 23,609 19,004 17,830 843 14,248 c 139
Results of viability test and cells morphology after 2 h culture are shown in Figure 3.
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3C), the addition of HNC in the concentration of 0.4 μg/mL (Figure 3D) and the mixture of AgNP + 
HNC in a concentration of 10 + 2 μg/mL (Figure 3G) showed a higher level of viability than the cells 
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Figure 3. Cardiac progenitor cell morphology and viability after 2 h of culture with AgNP and HNC;
(A) control culture; (B) culture with 2 µg/mL AgNP; (C) culture with 10 µg/mL AgNP; (D) culture with
0.4 µg/mL HNC; (E) culture with 2 µg/mL HNC; (F) culture with 2 µg/mL AgNP and 0.4 µg/mL HNC;
(G) culture with 10 µg/mL AgNP and 2 µg/mL HNC. (A–G) Series of viability in individual experimental
groups measured as fluorescence. a–d Statistically significant differences (p ≤ 0.05). Arrows indicate
agglomerates of HNC. Magnification 100×. Scale bars 200 µm. MFI—mean fluorescence intensity.
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CPC cultured in media containing the addition of AgNP at a concentration of 10 µg/mL (Figure 3C),
the addition of HNC in the concentration of 0.4 µg/mL (Figure 3D) and the mixture of AgNP + HNC in a
concentration of 10 + 2 µg/mL (Figure 3G) showed a higher level of viability than the cells in the control
culture. Moreover, none of the treated groups after 2 h had lower viability than the control group.
Regarding cells’ morphology on this stage, differences between experimental groups were not very
strong and easily visible yet. Cultures having higher viability have also visibly the highest confluence.
Results of the viability test and cell morphology changes after 24 h are presented in Figure 4.Materials 2020, 13, x FOR PEER REVIEW 9 of 18 
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were much smaller, spherical and possessed puckered and pleated cell membrane (Figure 4C,G). In 
the picture after Giemsa-May-Grünwald staining they did not appear to be alive, but the picture of a 
living culture (Figure 5) showed they were still intact, and some of them conducted slowly vital 
processes. Cells treated with the high concentration of HNC alone (2 μg/mL) were, in contrast, much 
bigger, less confluent (Figure 4E) and some of them had a number of nuclei. 
Figure 4. Cardiac progenitor cell morphology and viability after 24 h of culture with AgNP and HNC;
(A) control culture; (B) culture with 2 µg/mL AgNP; (C) culture with 10 µg/mL AgNP; (D) culture
with 0.4 µg/mL HNC; (E) culture with 2 µg/mL HNC; (F) culture with 2 µg/mL AgNP and 0.4 µg/mL
HNC; (G) culture with 10 µg/mL AgNP and 2 µg/mL HNC. (A–G) Series of viability in individual
experimental groups measured as fluorescence. a–d Statistically significant differences (p ≤ 0.05).
Magnification 100×. Scale bars 200 µm. MFI—mean fluorescence intensity.
Almost all of the CPC cultured in media containing an addition of any type and concentration of
nanomaterials showed stronger differences in viability than the control cells, except the group receiving
the mixture of AgNP + HNC in concentration 2 + 0.4 µg/mL (Figure 4F). Among the remaining groups,
a higher viability level was seen in cultures receiving the addition of the AgNP (2 µg/mL; Figure 4B)
and HNC (0.4 µg/mL and 2 µg/mL; Figure 4D,E). At the same time, both groups receiving AgNP
in a high concentration (10 µg/mL; Figure 4C) alone or in mixture with HNC (Figure 4G) showed
lower viability.
Differences in the cells’ morphology after 24 h were more pronounced than after 2 h culture.
CPC that received lower concentrations of nanomaterials (alone and in a mixture) were slightly smaller
but more numerous than the control cells (Figure 4B,D,F); in some places, they grew in a few layers
(Figure 4D).
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Higher concentrations of nanomaterials caused even stronger changes in the cells’ morphology.
CPC cultured in the presence of AgNP in a high concentration (10 µg/mL), alone and in a mixture,
were much smaller, spherical and possessed puckered and pleated cell membrane (Figure 4C,G). In the
picture after Giemsa-May-Grünwald staining they did not appear to be alive, but the picture of a living
culture (Figure 5) showed they were still intact, and some of them conducted slowly vital processes.
Cells treated with the high concentration of HNC alone (2 µg/mL) were, in contrast, much bigger,
less confluent (Figure 4E) and some of them had a number of nuclei.Materials 2020, 13, x FOR PE R REVIEW 10 of 18 
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Figure 6. Cardiac progenitor cell morphology and viability after 48 h of culture with AgNP and HNC;
(A) control culture; (B) culture with 2 µg/mL AgNP; (C) culture with 10 µg/mL AgNP; (D) culture
with 0.4 µg/mL HNC; (E) culture with 2 µg/mL HNC; (F) culture with 2 µg/mL AgNP and 0.4 µg/mL
HNC; (G) culture with 10 µg/mL AgNP and 2 µg/mL HNC. (A–G) Series of viability in individual
experimental groups measured as fluorescence. a–d Statistically significant differences (p ≤ 0.05).
Magnification 100×. Scale bars 200 µ . FI—mean fluorescence intensity.
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After 48 h the deepening differences in viability emerged, compared to the control group:
this meant that CPC receiving low concentrations of individual nanomaterials, i.e., 2 µg/mL of AgNP
and 0.4 µg/mL of HNC, had a higher viability level (Figure 6B,D), while cell cultures receiving high
concentration of AgNP (10µg/mL; Figure 6C,G) had a lower viability level (both alone and in mixture
with HNC). In the group receiving the mixture of AgNP + HNC in a concentration of 2 + 0.4 µg/mL
(Figure 6F) and HNC in high concentration (2 µg/mL; Figure 6E) no statistical differences in viability
level were noticed.
Differences in the cells’ morphology after 48 h were even more pronounced than after 24 h culture.
CPC that received lower concentrations of AgNP (alone and in the mixture; Figure 6B,F) were visibly
smaller and denser than control cells and cells after 24 h cell culture (Figure 4B,F). Cells that received a
low concentration of HNC (Figure 6D) looked similar to the control CPC for their dimensions and
density, but compared with the 24 h culture (Figure 4D) they were smaller and more numerous.
CPC cultured in a high concentration of AgNP (10 µg/mL), alone and in the mixture, after 48 h
were mostly dead. In the picture after Giemsa-May-Grünwald staining (Figure 6C,G), as well as in
the picture of living culture (Figure 7), only irregular debris of cells and cell membranes can be seen.
Probably if there were any living cells, they were singular. Cells treated with the high concentration of
HNC alone (2 µg/mL; Figure 6G) remained much bigger, and their confluence was visibly higher than
after 24 h (Figure 4G).
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Figure 7. Morphology of cardiac progenitor ce ls cultured with the addition of 10 µg/ L AgNP after
48 h. Magnifications: (A) 1 0×; (B) 2 0×; (C) 400×.
The res lts of recalculation of the viability rate of each experimental group on the relative viability
fold change, compared to the control gr up, are presented in Table 3.
Table 3. Cardiac progenitor cells relative viability fold change depending on time and treatment,
co pared to the control group; (A) control culture; (B) culture with 2 µg/ L g P; (C) culture ith
10 µg/ L AgNP; (D) culture with 0.4 µg/mL HNC; (E) culture with 2 µg/mL HNC; (F) culture with
2 µg/mL AgNP and 0.4 µg/mL HNC; (G) culture with 10 µg/mL AgNP and 2 µg/mL HNC.
Time
Treatment
A B C D E F G
2 h 1 1.42 1.46 1.48 0.98 1.29 1.78
24 h 1 1.18 0.08 1.42 1.23 1.02 0.11
48 h 1 1.20 0.03 1.33 1.07 1.00 0.05
It can be seen that nanomaterials changed CPC viability. Although it lowered in time for each of
the group as compared to the control, for some of them (low concentrations of separate nanomaterials),
it was always from 1.2- to 1.5-folds higher than for the control culture. With regard to groups receiving
the high concentration of AgNP alone or in mixture with HNC, even though relative viability of CPC
after 24 h declined drastically (about 15 times), and again after the next 24 h fell approximately twice,
after the first 2 h of culture, the highest values among all of the groups were seen.
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4. Discussion
The characteristics of both nanomaterials (AgNP and HNC) differ substantially, which is the reason
for the miscellaneous influence of these nanostructures on living cells and on each other. However,
the interaction between them, clearly visible on TEM pictures (Figure 1C,D), was probably due mainly
to the citric acid present in AgNP colloid. It is usually added in negligible concentration to all the
colloidal solutions of metallic nanoparticles to prevent their agglomeration. Citric acid is the metabolite
present in every living cell and taking part in the citric acid cycle (Krebs cycle) metabolising glucose
and lactate, but its extremely low concentration (immeasurable) in the culture medium could not be
harmful to cells as its addition was extremely low. Citric acid is commonly used as an additive and
stabiliser of acidity in dietary products in much higher concentrations. There are several papers related
to its application in human nutrition; for example, a paper by Pennistone et al. [29], where authors
assessed citric acid amount in natural and commercially available juices and determined its range at the
level of 1.4 g/oz, or an article by Chen et al. [30], where citric acid in a concentration of 10 g/L reduces
decay and maintains the postharvest quality of fruits. Our results of pH measurements in media
containing nanostructures, as can be seen in Figure 2b, showed no significant differences between
individual media, no matter whether citric acid was present in added nanostructures’ solutions or
not. Because the concentration of citric acid was negligible, and additionally was diluted by mixing of
the colloid with the HNC solution, it came to be too low to prevent AgNP agglomeration. Probably,
citric acid has also been adsorbed by the large surface of HNC, which became less compacted and
slightly changed its structure. As in the culture media, there are a lot of different biological components
that were probably able to act on nanomaterials in a similar way to citric acid in the colloid. However,
this influence was not identical for HNC and AgNP. With regard to AgNP, the media components were
sufficient to prevent aggregation, which confirms Figure 3C,G. CPC viability showed that cells reacted
on the nanomaterial and its mixture merely the same way, that suggested a very similar active surface
area of AgNP in both cases. Cellular responses to nanosilver were influenced by the physical and
chemical nature of AgNP and varied depending on the cell type. Smaller AgNP (diameter = ~10 nm)
penetrates into the cell, either by absorption into endosomes/lysosomes and endocytosis or by simple
diffusion through the cell membrane. In contrast, larger-sized nanosilver or large nanosilver aggregates
cannot enter the cell in this way, but can activate various signalling mechanisms through receptors that
lead to oxidative stress [31,32].
In the case of AgNP applied in our experiment, the size of nanoparticles ranged between 3 and
50 nm, so their effect on CPC was probably multidimensional, and at low concentrations, the effect
was not detrimental probably because of the sufficient mechanisms of exocytosis of the smaller
nanoparticles, and detoxification of the harmful products of their action. Additionally, it has not been
identified whether AgNP applied in mixture with HNC in the culture medium remained associated
with graphenic nanostructure, to predict whether they could easily penetrate inside cells or not.
It could not be observed by the mean of TEM because of the complex matrix of the mixture. For HNC,
the situation was different; Figure 3D revealed bigger agglomerates of HNC than Figure 3F, where a
slight amount of citric acid was added together with AgNP colloid.
Investigating studies on the activity of nanomaterials on living cells and organisms, they revealed
the physical properties and the size of nanomaterials influenced the effect that could be observed [33–35].
Zeta potential measurement can help to verify whether particles in suspension are robust against
aggregation. In our study, we performed such a measurement for water solutions and culture media
containing nanostructures and their mixtures used in the experiment in particular concentrations.
The absolute value of zeta potential higher than 30 mV testifies of the stability of a suspended substance
in the solution. The results of measurements presented in Table 1 and Figure 2, indicate that the zeta
potential of any of these suspensions did not exceed the absolute value of 30 mV. Moreover, measuring
zeta potential in these conditions showed that nanostructures in culture media are even less robust
against agglomeration than in water. It means that each of these nanomaterials separately and in
mixture tend to form aggregates no matter whether they were suspended in water or in a culture
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medium. However, comparing suspensions in water with suspensions in the medium could be seen
that the absolute value of zeta potential of the latter is lower. Furthermore, comparing these values for
individual suspensions in culture media could be seen that the media containing HNC alone and in
the mixture, no matter of concentrations, had significantly higher absolute zeta potential than media
containing AgNP and pure medium. These values, however, were still too low to ascertain the stability
of HNC nanostructures in the solution and prevent agglomeration. Such a process may lead to the loss
of properties associated with the nano-dimensional nature of the nanoparticles, since aggregates of
these materials have a reduced active surface area. To minimise the effect of aggregation, the suspension
was additionally sonicated each time, just before the preparation of the media, however, for HNC
this proved ineffective. Agglomerates of this nanostructure were clearly visible especially for its
high concentrations after 24 and even more after 48 h of culture (Figures 4E and 6E). Furthermore,
in Figure 3E,G few agglomerates could be seen which had dimensions higher than nano. Regarding
AgNP, Greulich et al. noted that they are unstable in terms of agglomeration; they reported, however,
that complexing AgNP with the foetal bovine serum present in the culture medium stabilised the
nanoparticles against aggregation [36]. On the basis of microscopic observations (Figures 3D, 4D
and 6D), we can conclude that HNC agglomerates in the culture medium and its stabilisation by the
foetal bovine serum present in the culture medium was also not effective. Although the zeta potential
plays a key role in defining the stability of suspensions, it does not specify the size distribution of
nanomaterials and their aggregates in the solution. The measurement of particle size with the DLS
method is also offered by ZetaSizer Nano ZS 90. Although it is possible for stable colloids it is not
proper for our nanostructures. When we tried to measure particle size the measurement could not be
finalised because nanostructures continuously aggregated and sedimented. Accordingly, the exact size
of the aggregates formed in cultures is not known. However, HNC agglomerates were much bigger
than those of AgNP alone, since the biggest of them can be distinguished on the microscope image
even in 100× magnification.
The influence of various concentrations of AgNP, HNC and their mixtures, on the viability and
morphology of CPC, was tested over time. The applied concentrations were selected on a base of
literature data and on a base of our previous experiments performed on microorganisms, living cells
and higher model organisms (chicken embryo and broiler chicken). We have chosen concentrations
about 3 to 5 times lower than those depicted as toxic by other researchers. It was found that the effect
depended on the time of culture, as well as on the type and the dose of nanomaterial. Multiway ANOVA
depicted the time as the main factor influencing cell viability (Table 2), so the comparison of changes in
CPC viability and morphology in the experimental groups differing by treatments was performed at
different time points.
Regarding the effect of the mentioned nanomaterials on CPC after 2 h, microscopic observation
and the viability test revealed that none of the nanomaterials, irrespective of the concentration applied
during this period of time, was harmful to CPC. Moreover, some of them seemed to enhance cell
viability and promote their proliferation. After 2 h of the experiment in all of the groups (not excluding
the control), few floating spherical cells detached from the surface were visible (Figure 3), however, this
is a normal phenomenon, as a small percentage of the elderly, or abnormal cells always die. After this
time, CPC morphology in all of the groups remained unchanged.
After prolonged culture (24 and 48 h), the results revealed longer exposure of CPC on mentioned
nanomaterials, the stronger it influenced the cells’ morphology and viability. AgNP at a lower
concentration did not affect the cells, whereas higher concentrations (either used alone or in combination
with HNC) led eventually to their death. In turn, HNC at the lower and higher concentrations affected
cell morphology, especially their dimensions. However, when the mixture of nanomaterials was
applied, regardless of the duration of culture, the effects on morphology level were not noted.
Comparing the results with other studies which applied the mentioned or very similar
nanomaterials and conducted the experiment on different types of cells can be ambiguous because the
morphology and function of various cell lines differ considerably.
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Results of the concentration-dependent cytotoxicity of silver nanoparticles published by Qin et al.,
on stem cells isolated from urine, showed that clear cytotoxicity of AgNP was noted after 24 h of exposure,
starting with a concentration of more than 4 µg/mL [37]. A similar result was obtained by Greulich
et al. who examined mesenchymal stem cells; they demonstrated that the concentration-dependent
cytotoxicity started with 3.5 µg/mL after 7 days of exposure to AgNP [34]. What is important is that
the concentration for eukaryotic cells was still higher than for the minimum inhibitory concentration
of silver nanoparticles for microorganisms, namely 0.7 ng/mL for Saccharomyces cerevisiae, 0.35 ng/mL
for Escherichia coli and 3.5 ng/mL for Staphylococcus aureus [38].
The dose of a substance can be defined as its quantity that reaches the biological system. It is
directly related to the exposure that is the concentration of the substance in the medium, multiplied by
the duration of contact [39]. Our results depict that CPC exposed to 2 µg/mL of AgNP for 48 h have an
even higher viability rate than cells in the control culture (Table 3), and probably could survive this
concentration of silver nanoparticles in culture medium for a longer time. Additionally, the proven
antimicrobial properties of AgNP [6–10] could allow the reduction or exclusion of antibiotics normally
applied as an addition to the medium in the culture.
Interpretation and comparison of the results of studies on HNC are quite difficult because so far
only two publications on the effect of this nanomaterial on the living cells have been published [40,41].
The first of these works showed that cytotoxicity of this material, tested on human glioblastoma cells
and fibroblasts, and on chicken red blood cells, increased with concentration and started from 10 µg/mL.
In the case of glioma cells, the authors found that their death was due to the activation of apoptosis
through the mitochondrial pathway, probably caused by the enhanced production of reactive oxygen
species. This phenomenon has been noticed for glioblastoma cells even at a concentration of 10 µg/mL
HNC in the culture medium, and was also dose-dependent, whereas at this concentration it was not
observed for healthy cells [40]. In red blood cells from the chicken embryo, in turn, a concentration of
10 µg/mL HNC applied in phosphate-buffered saline (PBS) solution turned out to be toxic evoking
cell haemolysis and deformation [41]. This effect could be due to the lack of protective effect of
culture medium compounds. The results corresponded with earlier reports dealing with other carbon
nanomaterials such as diamond, graphite or graphene. Liao et al. demonstrated that the graphene
flakes exhibit low toxicity to red blood cells and fibroblasts [42]. Talukdar et al., in turn, demonstrated
that the concentrations of the graphene nanoparticles of less than 50 µg/mL are relatively safe for
most cell types [43]. These findings, taking into account the physical properties of HNC as having a
very high relative surface area, encourages their application as nanocarriers in future experiments.
With the progress of the culture, more and more agglomerates of HNC were observed; it was, however,
not possible to determine whether HNC entered the cells, or was deposited on their surfaces. The high
specific surface area of HNC is likely to block or prevent particles entering inside the cell, however,
similar presumptions applied to graphene. Graphene did not enter the cell it gathered around,
suggesting the existence of a high affinity for the cells [20]. On the other hand, some authors have
reported the possibility of endocytosis of carbon nanomaterials, for example, Wang et al. observed
graphene oxide in human fibroblasts, which increased with the progress of culture [44].
Confluence, appearance and the number of CPC treated with the mixture of AgNP and HNC at
the concentration (2 AgNP + 0.4 HNC) µg/mL (Figures 4D and 6D), were at a similar level as the control
culture. Their appearance was more like a cell culture treated with AgNP at a concentration of 2 µg/mL
than cells exposed to HNC at a concentration of 0.4 µg/mL. Shrinking, and a loss of adhesiveness
was not observed. There are some studies on the different ways of silver nanoparticles’ action on
living cells. Qin et al. found that cells treated with AgNP concentration of 2 µg/mL had an increased
expression of key genes of differentiation. AgNP-induced actin polymerisation increased the tension
of the cytoskeleton, resulting in osteogenic differentiation of stem cells isolated from the urine [35].
After 24 and 48 h treatments of CPC with a mixture of AgNP and HNC, at a concentration of
(10 AgNP + 2HNC) µg/mL (Figures 4G and 6G), there was a significant reduction in the number of
cells. Cells did not undergo staining (neither the nucleus nor the body of the cell) which suggests that
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the cells were dead; therefore, it can be assumed that AgNP was primarily responsible for the cytotoxic
effect on the cells.
Tests of the cells’ viability revealed interesting relationships. CPC of our experiment treated with
HNC nanostructures at 0.4 µg/mL (Table 3) had a higher viability level than the control cells, and this
difference persisted over time and declined very slowly. These changes were not observed in the case
of cells treated with a higher concentration of HNC. This time, the viability level of CPC remained the
same, as in the case of control culture (Table 3).
A stronger influence was seen at the level of the cells’ morphology. Cells treated with 2 µg/mL
HNC in the medium were distinctly bigger than the other cells in the experiment. It can, therefore,
be concluded that HNC, even at such a low concentration, affects cells and influences their viability
level and morphological changes. CPC from our experiment treated with HNC nanostructures at
0.4 µg/mL (Table 3), stood out from the other groups, as their viability was the highest. One of the
reasons why the viability level in this group was increased could be the activation of treated cells on the
first day of the incubation with HNC, to neutralise the “foreign” component of the medium. The most
surprising result was the strong activation of cells treated with HNC at the concentration of 0.4 µg/mL.
Perhaps, this concentration most effectively affected cells, which after prolonged exposure (as shown
in Figure 6D) were the most numerous (or most active). Probably, HNC is not a nanomaterial that
inflicts death to cells but only reduces their adhesion to the surface. In Figure 4D, the upper layer of
the cells seems to be detached from the bottom, together with HNC agglomerates. The reason for this
phenomenon is not clear, however, cells might respond this way by treating HNC as a biocompatible
scaffold and attaching to the nanostructure more willingly than to the bottom of culture flask. Moreover,
it may be due to the limitation of transport through the cell membrane as well.
A factor that contributes to the fact that the culture of CPC with (2 AgNP + 0.4HNC) µg/mL
was similar to the control culture could be the mutual neutralising effect of AgNP and HNC at this
concentration, after 24 and 48 h culture (Figure 4A,F and Figure 6A,F). However, as observed from
the fluorescence measurement, protective action on cell viability was not manifested in the increased
levels of nanomaterials in the mixture. This effect could be due to the rising tendency of HNC to
aggregate in higher concentrations, that can also be seen in Figures 4E and 6E. More agglomerated
material exerted a less neutralising effect on AgNP and less influence on growing cells also because it
had a smaller specific surface available for the interaction with them. In case of application of AgNP at
a concentration of 10 µg/mL and the mixture of nanomaterials (10 AgNP + 2HNC) µg/mL, the viability
measurement confirmed the changes on cell morphology and confluence observed during cell culture.
The level of viability of cells exposed to these factors was very low. As assumed above, the impact of
AgNP was more pronounced and mainly responsible for the obtained effects. The reason for such a
significant decline in viability could be structural and functional damage to the mitochondria, which
ultimately resulted in cell death. Cell death, however, is not the only cause of the decline of viability
levels, as it can be also a consequence of a big slowdown or limitation of their vital functions [45].
Summarising, the viability test results showed that the time is the strongest factor influencing cells
viability, no matter of treatment applied. Moreover, the viability test results coincide with microscopic
observations of CPC treated with AgNP at concentrations of 2 µg/mL and 10 µg/mL alone, as well as in
mixture with HNC. They revealed a dose-dependent manner of AgNP action, where, between the two
applied concentrations lies a border between their probable beneficial effect and toxicity. Moreover,
it was shown that in the mixture, the action of AgNP is stronger than HNC. The same test indicated also
that the cells treated with HNC at a concentration of 0.4 µg/mL had higher viability than the control
cells over time. As regards the case of HNC at a concentration of 2 µg/mL, cell viability was almost the
same as of the control group, but after prolonged culture, they were morphologically different, and the
number of cells was slightly lower.
These phenomena are due to the fact that cell viability/morphology could be changed after
prolonged exposure to nanomaterials because they tended to deposit with time on the surface of cells,
that leads to closer contact and stronger influence on CPC.
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5. Conclusions
AgNP and HNC at low concentrations upregulated CPC viability in vitro. High concentrations of
AgNP drastically downregulated CPC viability, even applied in mixture with HNC. High concentrations
of HNC did not affect CPC viability but strongly influenced their morphology and abundance. It is
necessary to perform further research examining the mechanisms of action of mentioned nanostructures
on CPC and probably other cells of a pluripotent nature as well.
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